Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

被引：0
|
作者：
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构：
[1] Novartis Institutes for BioMedical Research,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Pvt. Ltd,undefined
来源：
European Journal of Clinical Pharmacology | 2015年 / 71卷
关键词：
Pharmacokinetics; Drug-drug interaction; Pradigastat; Acetaminophen; Gastric motility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 432
页数：7
相关论文
共 50 条
  • [1] Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects
    Ayalasomayajula, Surya
    Meyers, Dan
    Koo, Phillip
    Salunke, Atish
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (04) : 425 - 432
  • [2] Assessment of Pharmacokinetic Drug-Drug Interaction Between Pradigastat and Atazanavir or Probenecid
    Mendonza, Anisha
    Hanna, Imad
    Meyers, Dan
    Koo, Phillip
    Neelakantham, Srikanth
    Zhu, Bing
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 355 - 364
  • [3] Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin
    Yan, Jing-He
    Meyers, Dan
    Lee, Zachary
    Danis, Kate
    Neelakantham, Srikanth
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07): : 800 - 808
  • [4] ASSESSMENT OF PHARMACOKINETIC INTERACTION BETWEEN PRADIGASTAT AND ATAZANAVIR OR PROBENECID IN HEALTHY SUBJECTS
    Mendonza, A.
    Meyers, D.
    Koo, P.
    Neelakantham, S.
    Majumdar, T.
    Rebello, S.
    Sunkara, G.
    Chen, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S79 - S79
  • [5] Absence of pharmacokinetic drug-drug interaction between telbivudine and lamivudine or adefovir in healthy subjects
    Zhou, XJ
    Lloyd, DM
    Fielman, BA
    Maureen, MW
    Chao, C
    JOURNAL OF HEPATOLOGY, 2005, 42 : 197 - 198
  • [6] Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects
    Desai, Amit
    Yamazaki, Takao
    Dietz, Albert J.
    Kowalski, Donna
    Lademacher, Christopher
    Pearlman, Helene
    Akhtar, Shahzad
    Townsend, Robert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 86 - 92
  • [7] ASSESSMENT OF PHARMACOKINETIC INTERACTION BETWEEN PRADIGASTAT AND EFAVIRENZ OR REPAGLINIDE IN HEALTHY SUBJECTS.
    Kulmatycki, K. M.
    Meyers, D.
    Danis, K.
    Neelakantham, S.
    Su, Z.
    Majumdar, T.
    Sam, R.
    Sunkara, G.
    Chen, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S48 - S49
  • [8] Pharmacokinetic Drug-Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants
    Kim, Dong Ho
    Hong, Jang Hee
    Jung, Won Tae
    Nam, Kyu-Yeol
    Roh, Jae Seok
    Lee, Hye Jung
    Moon, JungHa
    Kim, Kyu Yeon
    Jung, Jin-Gyu
    Sunwoo, Jung
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 267 - 276
  • [9] Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
    Trivedi, Ashit
    Sohn, Winnie
    Hsu, Cheng-Pang
    Jafarinasabian, Pegah
    Zhang, Hanze
    Hutton, Shauna
    Flach, Stephen
    Abbasi, Siddique
    Dutta, Sandeep
    Lee, Edward
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (03): : 388 - 396
  • [10] Randomized pharmacokinetic and drug-drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects
    Das, Shampa
    Li, Jianguo
    Armstrong, Jon
    Learoyd, Maria
    Edeki, Timi
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (05):
12345